Aclaris Therapeutics - 48 Year Dividend History | ACRS

Historical dividend payout and yield for Aclaris Therapeutics (ACRS) since 1971. The current TTM dividend payout for Aclaris Therapeutics (ACRS) as of December 06, 2019 is $0.00. The current dividend yield for Aclaris Therapeutics as of December 06, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.069B $0.010B
Aclaris Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing drugs to met needs in dermatology. Its drug candidate consists of A-101, a high-concentration hydrogen peroxide topical solution which is being developed as a prescription treatment for seborrheic keratosis a common non-malignant skin tumor and A-102, a proprietary topical gel dosage form of hydrogen peroxide for the treatment of SK and common warts which are in different clinical trial. Aclaris Therapeutics, Inc. is headquartered in Malvern, Pennsylvania.
Stock Name Country Market Cap PE Ratio